|
Volumn 25, Issue 4, 2004, Pages 357-358
|
Letter to the editors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHORIONIC GONADOTROPIN;
CYTOKERATIN;
VIMENTIN;
INTERLEUKIN 2 RECEPTOR;
ANIMAL EUTHANASIA;
ANIMAL TISSUE;
CHORION VILLUS;
DECIDUA;
DONOR;
ENDOMETRIUM;
ERYTHROCYTE;
EXPERIMENTAL MODEL;
FETOPLACENTAL UNIT;
GESTATIONAL AGE;
GRAFT SURVIVAL;
HEALTH STATUS;
HISTOCHEMISTRY;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
IMMUNOASSAY;
IMMUNOHISTOLOGY;
IN VIVO STUDY;
KIDNEY;
LETTER;
MOUSE;
NONHUMAN;
OVARY;
PLACENTA VILLUS;
PLACENTAL TRANSFER;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
RECIPIENT;
TISSUE CULTURE;
TISSUE GRAFT;
TISSUE GROWTH;
TISSUE TRANSPLANTATION;
TROPHOBLAST;
UTERUS;
XENOTRANSPLANTATION;
ADULT;
ANIMAL;
CELL CULTURE;
CELL TRANSPLANTATION;
CULTURE TECHNIQUE;
CYTOLOGY;
FEMALE;
METHODOLOGY;
MOUSE MUTANT;
PHYSIOLOGY;
PREGNANCY;
TRANSPLANTATION;
XENOGRAFT;
ADULT;
ANIMALS;
CELL CULTURE TECHNIQUES;
CELL TRANSPLANTATION;
CELLS, CULTURED;
CHORIONIC VILLI;
FEMALE;
HUMANS;
MICE;
MICE, KNOCKOUT;
PREGNANCY;
RECEPTORS, INTERLEUKIN-2;
TRANSPLANTATION, HETEROLOGOUS;
TROPHOBLASTS;
|
EID: 1942519689
PISSN: 01434004
EISSN: None
Source Type: Journal
DOI: 10.1016/j.placenta.2003.09.006 Document Type: Letter |
Times cited : (10)
|
References (2)
|